← FDA DRUG APPROVALS

FDA ANDA · ANDA080963

PIPERAZINE CITRATE

Sponsor: LANNETT

APPLICATION
ANDA080963
TYPE
ANDA
ORIGINAL APPROVAL
1974-07-25
LATEST ACTION
1986-06-17
ROUTE
ORAL
DOSAGE FORM
SYRUP
MARKETING STATUS
Discontinued

Products

PIPERAZINE CITRATEDiscontinued
PIPERAZINE CITRATE EQ 500MG BASE/5ML · SYRUP · ORAL

Approval history

1986-06-17Manufacturing (CMC) · Supplement 3AP
1974-07-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →